Erweka
High-quality tablet testing equipment for the pharmaceutical industry, featuring advanced dissolution software and enhanced process safety.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Erweka operates as a manufacturer of tablet testing equipment, serving the pharmaceutical and life science sectors. The company's client base includes large pharmaceutical corporations, research and testing laboratories, and academic institutions globally.
Its business model is centered on the development, production, and sale of specialized hardware and software for quality control and research. A specific product mentioned is a full dissolution software solution for the flow-through cell Disso, which is designed to increase process safety by reducing the number of seals required. The equipment also features a compact, corrosion-resistant housing.
Erweka is part of the Verder Group, a family-owned technology conglomerate with over 1700 employees. It functions within the group's Scientific Division, which comprises nine manufacturing locations focused on equipment for quality control and R&D of solid matter.
Keywords: tablet testing, pharmaceutical equipment, life sciences, quality control, research and development, dissolution testing, laboratory equipment, Verder Group, process safety, manufacturing